Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction

J Exp Med. 1993 Dec 1;178(6):2115-21. doi: 10.1084/jem.178.6.2115.

Abstract

A bacterial pathogen that is important in both urinary tract and intestinal infections is Escherichia coli which expresses Dr or related adhesins. In this report, we present a model for testing cell-cell interaction, using both molecularly characterized laboratory cells that express recombinant molecules of human decay-accelerating factor (DAF), and recombinant bacterial Dr colonization factors. Dr adhesin ligand was identified as DAF (CD55), a membrane protein that protects autologous tissues from damage due to the complement system. Structure-function studies mapped the adhesin-binding site on the DAF molecule. A single-point substitution in the third short consensus repeat domain, Ser165 to Leu, corresponding to the Dra to Drb allelic polymorphism, caused complete abolition of adhesin binding to DAF.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adhesins, Escherichia coli
  • Antigens, Bacterial / metabolism*
  • Antigens, CD / chemistry
  • Antigens, CD / metabolism*
  • Bacterial Adhesion*
  • Bacterial Outer Membrane Proteins / metabolism*
  • Binding Sites
  • CD55 Antigens
  • Cell Adhesion*
  • Humans
  • In Vitro Techniques
  • Ligands
  • Membrane Glycoproteins / chemistry
  • Membrane Glycoproteins / metabolism*
  • Protein Binding
  • Recombinant Proteins
  • Structure-Activity Relationship

Substances

  • Adhesins, Escherichia coli
  • Antigens, Bacterial
  • Antigens, CD
  • Bacterial Outer Membrane Proteins
  • CD55 Antigens
  • Ligands
  • Membrane Glycoproteins
  • Recombinant Proteins